Building a platform where frontier science meets the health needs of ordinary Brazilians
In Campinas, Brazil, President Lula inaugurated four new research lines at the Sirius particle accelerator, opening pathways into the atomic and molecular world that few nations have the capacity to explore. Backed by R$800 million in public investment, the expansion reflects a deeper ambition: to transform scientific infrastructure into a foundation for technological self-reliance. At a moment when semiconductors, critical minerals, and pharmaceutical sovereignty define geopolitical power, Brazil is choosing to build rather than borrow.
- Brazil's most powerful scientific instrument just gained four new research lines — each one targeting a frontier where the country has long depended on foreign technology.
- The R$800 million expansion of Sirius arrives amid global competition over semiconductors, rare earth minerals, and pharmaceutical supply chains, making the stakes of this inauguration far larger than a single laboratory.
- A parallel R$65 million health innovation program was unveiled alongside the accelerator expansion, signaling that the government is linking cutting-edge physics directly to the everyday health needs of ordinary Brazilians.
- Construction of the Orion pathogen research complex — the first in the world connected directly to a synchrotron light source — continues at R$1.4 billion, deepening the institutional bet on domestic scientific capacity.
- Officials acknowledge the strategy will take years to bear fruit, but frame it as essential: a country that cannot design and manufacture its own critical technologies remains structurally dependent on those that can.
On a Monday morning in Campinas, President Lula inaugurated four new research lines at the Sirius particle accelerator — named Tatu, Sapucaia, Quati, and Sapê — completing the second phase of a project that has now absorbed R$800 million in new public investment, on top of R$2 billion spent in earlier phases. Sirius functions as a supermicroscope, generating synchrotron light to reveal the atomic and molecular structure of matter, from proteins and pharmaceutical compounds to the rare earth minerals and semiconductor components that underpin modern electronics.
Each new line opens a distinct scientific frontier. Tatu investigates quantum materials and nanophotonic systems with implications for telecommunications and light-based computing. Sapucaia targets nanoparticles, proteins, and medicinal compounds, including joint research with China. Quati enables study of materials used in petrochemicals, pharmaceuticals, and critical mineral extraction. Sapê focuses on advanced energy materials and semiconductor development — the building blocks of next-generation chips.
The inauguration was paired with the launch of the National Program for Radical Innovation in Health, seeded with R$65 million and projected to reach R$600 million over five years. Its stated goal is technological sovereignty in health — building domestic capacity to design and manufacture medical technologies Brazil currently imports. The Cnpem, which houses Sirius, will anchor the program.
Separately, the Orion complex — a pathogen research laboratory that will be the first in the world connected directly to a synchrotron light source — continues construction at a cost of R$1.4 billion. Taken together, these investments represent a deliberate national wager: that building scientific capacity at home, however slowly, is more durable than purchasing it from abroad.
On Monday morning in Campinas, President Luiz Inácio Lula da Silva stood before Brazil's most powerful scientific instrument and opened four new doors into the invisible world of atoms and molecules. The Sirius particle accelerator, a machine that functions as a kind of supermicroscope, had just received four new research lines—named Tatu, Sapucaia, Quati, and Sapê—funded with R$800 million in public investment. The inauguration marked the completion of the second phase of a project that began with R$2 billion in earlier spending, all of it channeled through the Novo PAC development program under the Ministry of Science, Technology and Innovation.
The Sirius works by generating synchrotron light, a form of electromagnetic radiation that can penetrate matter and reveal its atomic and molecular structure. Scientists use this light to examine everything from proteins and pharmaceutical compounds to the rare earth minerals and semiconductor components that power modern electronics. Each of the four new lines targets a different frontier of research. Tatu investigates quantum materials and nanophotonic systems, work that could reshape telecommunications and light-based computing. Sapucaia focuses on nanoparticles, proteins, and medicinal compounds, including collaborative research with China. Quati opens pathways for studying materials used in petrochemicals, pharmaceuticals, and the extraction of critical minerals. Sapê concentrates on advanced materials for energy applications and semiconductor development—the building blocks of next-generation computer chips.
The timing of the announcement reflected a broader Brazilian strategy to reduce dependence on imported technology. Alongside the Sirius inauguration, the government unveiled the National Program for Radical Innovation in Health, a separate initiative seeded with R$65 million and projected to grow to R$600 million over five years. The program aims to strengthen what officials call technological sovereignty in health—developing domestic capacity to design and manufacture medical technologies that the Brazilian health system currently imports. Adriano Massuda, the executive secretary of the Ministry of Health, described the moment as historic, saying the country was building a national platform capable of connecting cutting-edge science with productive innovation and the concrete health needs of ordinary Brazilians.
The Cnpem, the National Center for Energy and Materials Research that houses Sirius, became the anchor institution for this health innovation program. Separately, construction continues on the Orion complex, a laboratory for advanced pathogen research that will be the first of its kind in the world to be directly connected to a synchrotron light source. That facility carries a price tag of R$1.4 billion, also funded through the Novo PAC. Together, these investments represent a deliberate bet that Brazil can build scientific and technological capacity at home rather than purchasing it abroad—a shift in strategy that will take years to bear fruit but that officials believe is essential to the country's long-term development.
Citas Notables
We are building a national platform of technological sovereignty in health, capable of connecting frontier science, productive innovation, and the concrete health needs of the Brazilian people.— Adriano Massuda, executive secretary of the Ministry of Health
La Conversación del Hearth Otra perspectiva de la historia
What exactly does this Sirius machine do that makes it worth R$800 million in new investment?
It's essentially a microscope that uses a special kind of light to see the structure of materials at the atomic level. That lets researchers understand how drugs work, how to design better semiconductors, what's inside rare minerals. Things you can't see any other way.
And these four new lines—are they separate machines, or different capabilities of the same machine?
Different capabilities. Think of them as four new workstations, each one designed to answer different kinds of questions. One focuses on quantum materials, another on proteins and medicines, another on critical minerals, another on semiconductors.
Why does Brazil care so much about doing this research domestically instead of just buying the technology from other countries?
Because if you depend on imports, you're always behind. You pay more, you wait longer, and you have no control over your own supply chain. The government is betting that building this capacity now means Brazil can develop its own medicines, its own chips, its own materials—and sell them too.
The health innovation program seems separate from Sirius. How do they connect?
Sirius is the tool. The health program is the strategy for using that tool. Sirius can help researchers understand how to make better drugs and medical devices. The health program channels that research toward things the Brazilian health system actually needs.
Is this realistic? Can Brazil really reduce its dependence on imported medical technology in five years?
Five years is just the beginning. The R$65 million initial investment grows to R$600 million over that period. It's a long game. But yes, if the research produces results and gets connected to manufacturing, it's possible.